TY - JOUR
T1 - Association of Myocardial Blood Flow Reserve with Adverse Left Ventricular Remodeling in Patients with Aortic Stenosis
T2 - The Microvascular Disease in Aortic Stenosis (MIDAS) Study
AU - Zhou, Wunan
AU - Sun, Yee Ping
AU - Divakaran, Sanjay
AU - Bajaj, Navkaranbir S.
AU - Gupta, Ankur
AU - Chandra, Alvin
AU - Morgan, Victoria
AU - Barrett, Leanne
AU - Martell, Laurel
AU - Bibbo, Courtney F.
AU - Hainer, Jon
AU - Lewis, Eldrin F.
AU - Taqueti, Viviany R.
AU - Dorbala, Sharmila
AU - Blankstein, Ron
AU - Slomka, Piotr
AU - Shah, Pinak B.
AU - Kaneko, Tsuyoshi
AU - Adler, Dale S.
AU - O'Gara, Patrick
AU - Di Carli, Marcelo F.
N1 - Publisher Copyright:
© 2021 American Medical Association. All rights reserved.
PY - 2022/1
Y1 - 2022/1
N2 - Importance: Impaired myocardial flow reserve (MFR) and stress myocardial blood flow (MBF) on positron emission tomography (PET) myocardial perfusion imaging may identify adverse myocardial characteristics, including myocardial stress and injury in aortic stenosis (AS). Objective: To investigate whether MFR and stress MBF are associated with LV structure and function derangements, and whether these parameters improve after aortic valve replacement (AVR). Design, Setting, and Participants: In this single-center prospective observational study in Boston, Massachusetts, from 2018 to 2020, patients with predominantly moderate to severe AS underwent ammonia N13 PET myocardial perfusion imaging for myocardial blood flow (MBF) quantification, resting transthoracic echocardiography (TTE) for assessment of myocardial structure and function, and measurement of circulating biomarkers for myocardial injury and wall stress. Evaluation of health status and functional capacity was also performed. A subset of patients underwent repeated assessment 6 months after AVR. A control group included patients without AS matched for age, sex, and summed stress score who underwent symptom-prompted ammonia N13 PET and TTE within 90 days. Exposures: MBF and MFR quantified on ammonia N13 PET myocardial perfusion imaging. Main Outcomes and Measures: LV structure and function parameters, including echocardiographic global longitudinal strain (GLS), circulating high-sensitivity troponin T (hs-cTnT), N-terminal pro-B-type natriuretic peptide (NT-pro BNP), health status, and functional capacity. Results: There were 34 patients with AS (1 mild, 9 moderate, and 24 severe) and 34 matched control individuals. MFR was independently associated with GLS and LV ejection fraction, (β,-0.31; P =.03; β, 0.41; P =.002, respectively). Stress MBF was associated with hs-cTnT (unadjusted β, -0.48; P =.005) and log NT-pro BNP (unadjusted β, -0.37; P =.045). The combination of low stress MBF and high hs-cTnT was associated with higher interventricular septal thickness in diastole, relative wall thickness, and worse GLS compared with high stress MBF and low hs-cTnT (12.4 mm vs 10.0 mm; P =.008; 0.62 vs 0.46; P =.02; and -13.47 vs -17.11; P =.006, respectively). In 9 patients studied 6 months after AVR, mean (SD) MFR improved from 1.73 (0.57) to 2.11 (0.50) (P =.008). Conclusions and Relevance: In this study, in AS, MFR and stress MBF were associated with adverse myocardial characteristics, including markers of myocardial injury and wall stress, suggesting that MFR may be an early sensitive marker for myocardial decompensation.
AB - Importance: Impaired myocardial flow reserve (MFR) and stress myocardial blood flow (MBF) on positron emission tomography (PET) myocardial perfusion imaging may identify adverse myocardial characteristics, including myocardial stress and injury in aortic stenosis (AS). Objective: To investigate whether MFR and stress MBF are associated with LV structure and function derangements, and whether these parameters improve after aortic valve replacement (AVR). Design, Setting, and Participants: In this single-center prospective observational study in Boston, Massachusetts, from 2018 to 2020, patients with predominantly moderate to severe AS underwent ammonia N13 PET myocardial perfusion imaging for myocardial blood flow (MBF) quantification, resting transthoracic echocardiography (TTE) for assessment of myocardial structure and function, and measurement of circulating biomarkers for myocardial injury and wall stress. Evaluation of health status and functional capacity was also performed. A subset of patients underwent repeated assessment 6 months after AVR. A control group included patients without AS matched for age, sex, and summed stress score who underwent symptom-prompted ammonia N13 PET and TTE within 90 days. Exposures: MBF and MFR quantified on ammonia N13 PET myocardial perfusion imaging. Main Outcomes and Measures: LV structure and function parameters, including echocardiographic global longitudinal strain (GLS), circulating high-sensitivity troponin T (hs-cTnT), N-terminal pro-B-type natriuretic peptide (NT-pro BNP), health status, and functional capacity. Results: There were 34 patients with AS (1 mild, 9 moderate, and 24 severe) and 34 matched control individuals. MFR was independently associated with GLS and LV ejection fraction, (β,-0.31; P =.03; β, 0.41; P =.002, respectively). Stress MBF was associated with hs-cTnT (unadjusted β, -0.48; P =.005) and log NT-pro BNP (unadjusted β, -0.37; P =.045). The combination of low stress MBF and high hs-cTnT was associated with higher interventricular septal thickness in diastole, relative wall thickness, and worse GLS compared with high stress MBF and low hs-cTnT (12.4 mm vs 10.0 mm; P =.008; 0.62 vs 0.46; P =.02; and -13.47 vs -17.11; P =.006, respectively). In 9 patients studied 6 months after AVR, mean (SD) MFR improved from 1.73 (0.57) to 2.11 (0.50) (P =.008). Conclusions and Relevance: In this study, in AS, MFR and stress MBF were associated with adverse myocardial characteristics, including markers of myocardial injury and wall stress, suggesting that MFR may be an early sensitive marker for myocardial decompensation.
UR - http://www.scopus.com/inward/record.url?scp=85115222053&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85115222053&partnerID=8YFLogxK
U2 - 10.1001/jamacardio.2021.3396
DO - 10.1001/jamacardio.2021.3396
M3 - Article
C2 - 34524397
AN - SCOPUS:85115222053
SN - 2380-6583
VL - 7
SP - 93
EP - 99
JO - JAMA Cardiology
JF - JAMA Cardiology
IS - 1
ER -